"Zynerba, a clinical-stage specialty pharmaceutical, is developing next-gen synthetic cannabinoid treatments formulated for transdermal delivery. A transdermal patch is intended to allow sustained and controlled delivery of two the company’s therapeutic cannabinoids: cannabidiol (CBD), a...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.